668479-38-7 Usage
Uses
Used in Chemical Research and Synthesis:
L-Leucine, N,N'-[1,4-phenylenebis(1-oxo-2,1-ethanediyl)]bis-, dimethyl ester is used as a chemical intermediate for the synthesis of various compounds. Its unique structure allows it to participate in a range of chemical reactions, facilitating the development of new molecules with potential applications in various fields.
Used in Pharmaceutical Development:
In the field of medicine, L-Leucine, N,N'-[1,4-phenylenebis(1-oxo-2,1-ethanediyl)]bis-, dimethyl ester may have potential applications in the development of pharmaceuticals. Its structure could be incorporated into drug molecules to target specific biological pathways or receptors, potentially leading to the discovery of new therapeutic agents.
Used in Biochemical Studies:
L-Leucine, N,N'-[1,4-phenylenebis(1-oxo-2,1-ethanediyl)]bis-, dimethyl ester may also be utilized in biochemical research to study the interactions between amino acids and other biomolecules. Understanding these interactions could provide insights into the fundamental processes of life and contribute to the development of new biocatalysts or biomaterials.
Used in Cosmetics Industry:
Although not explicitly mentioned in the provided materials, the compound's potential use in the cosmetics industry cannot be ruled out. Given its structural features, it may be employed as an ingredient in cosmetic formulations to enhance the properties of the final product, such as improving skin hydration or providing antioxidant benefits.
Check Digit Verification of cas no
The CAS Registry Mumber 668479-38-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 6,6,8,4,7 and 9 respectively; the second part has 2 digits, 3 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 668479-38:
(8*6)+(7*6)+(6*8)+(5*4)+(4*7)+(3*9)+(2*3)+(1*8)=227
227 % 10 = 7
So 668479-38-7 is a valid CAS Registry Number.
668479-38-7Relevant academic research and scientific papers
Radau, Gregor
, p. 1159 - 1166 (2003)
Choosing the best conditions and pathways for the synthesis of peptidic compounds remains a challenge for the peptide chemist. Our efforts towards the syntheses of two precursors of potential tryptase inhibitors, building block A and B, led to the development of two different synthesis routes. Each of them is successful in the synthesis of only one of the two, structurally nearly identical target compounds.
